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The extracellular domain of rabbit prolactin receptor (rbPRLR-ECD) expressed in an insectlbaculovirus expression system was purified by affinity 
chromatography on immobilized PRL followed by gel filtration. The purified protein was over 90% homogeneous as indicated by SDS-PAGE in 
the presence or absence of reducing agent, and by chromatography on a Superdex column. Its molecular mass determined by SDS-PAGE was 32 
kDa, and by gel filtration, 27 kDa. Both values are higher than the 22.8 kDa deduced from the cDNA sequence, indicating extensive glycosylation. 
The K, value for interaction with ovine (0) PRL was 25.4 nM_‘, but even at high rbPRLR-ECD:hormone molar ratios, the stoichiometry of 
interaction with oPRL or human growth hormone indicated formatron of only 1: 1 complexes, in contrast to human growth hormone (hGH)-ECD 
which forms 2:1 complexes with hGH. 
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1. INTRODUCTION 
Numerous indirect studies have indicated that recep- 
tor dimerization is an initial step in the prolactin (PRL) 
signal transduction that occurs subsequent to hormone 
binding [14]. Direct evidence for dimerization of re- 
combinant, non-glycosylated human growth hormone 
(hGH) receptor’s extracellular domain (hGHR-ECD) 
containing amino acids l-238 out of a total of 246 due 
to interaction with hGH, has been recently provided by 
biochemical [5] and X-ray crystallographic studies [6], 
in which two non-symmetrical binding sites in hGH 
were identified. A similar 2:l stoichiometry of hGHR- 
ECD:hGH interaction was also observed in our lab 
using full-size (l-246) hGHR-ECD [7]. Hormone-in- 
duced receptor dimerization may be characteristic of an 
entire family of GH/PRL/cytokine receptors [8]. This is 
indicated by a recent report that in a leukemia cell line 
expressing a hybrid receptor composed of the ECD of 
hGHR linked to the transmembrane and intracellular 
domains of murine granulocyte colony-stimulating fac- 
tor receptor, monoclonal antibodies to hGHR stimu- 
lated DNA synthesis while their Fab fragments were 
devoid of mitogenic activity [9]. 
we decided to study whether hormone-induced receptor 
dimerization also occurs in the PRL:PRLR interaction. 
Recently, we have produced and expressed the ECD of 
rabbit (rb) PRLR using an insect/baculovirus expres- 
sion system [12]. In the present work, we describe its 
purification and interaction with two lactogenic 
hormones, ovine (0) PRL and hGH. 
2. MATERIALS AND METHODS 
2.1. Materials 
Ovine PRL (NIDKK AFP-8277E) and human GH (AFP-4793 B) 
were received from the National Hormone and Pituitary Programs 
(Bethesda, MD, USA). Recombinant hGHR-ECD (hGH binding pro- 
tein) containing l-246 amino acids and expressed in E. coli was pre- 
pared as described previously [7]. Reagents for tissue culture are listed 
in a former publication [12]. All other reagents were of analytical 
grade. 
2.2. Preparation of insect cells’ conditioned medium 
Since GHs and PRLs [lo], as well as the ECDs of 
their receptors, exhibit a high degree of similarity [l 11, 
The growth of Spodoptera fiugipedra (SF 9) insect cells has been 
described previously [12]. Confluent cell cultures (grown in spinner 
flasks to 34 x lo6 cells/ml) were transferred to 175-cm* tissue culture 
flasks (Nunc, Kamstrup, Denmark) and seeded at 55 x lo6 cells/flask. 
After infection wtth a recombinant baculovirus containing the pGM 
Ac3 E rb PRLRL [12], the cells were cultured at 27°C in serum-free 
SF-900 medium. After 3 days, the conditioned medmm containing the 
PRLR-ECD was collected, centrifuged for 15 min at 1,200 x g and 
stored at -20°C. 
2.3. Preparation of oPRL-Afjgel column 
Correspondence address, A. Gertler, Department of Biochemistry, The column was prepared according to the method of Shiu and 
Food Science and Nutrition, Faculty of Agriculture, The Hebrew Friesen [13]. One ml of resin contained 0.5-0.6 mg of oPRL. The same 
University of Jerusalem, PO Box 12, Rehovot 76100, Israel. Fax: (972) column was used for five successive rbPRLR-ECD preparations, after 
(8) 47 6189. reequilibration with the running buffer. 
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2.4. SDS-polyacrylamide gel electrophoresis and Western blot analyses 
SDS-PAGE was carried out according to Laemmli using 10% gels 
[14]. The gels were stained with Coomassie blue. The protocol for 
Western blot analyses was as described previously [I 21. 
2.5. Binding assays 
The binding assays and Scatchard analyses were performed as de- 
scribed previously, using goat anti-rbPRLR polyclonal antibody 46 
for immunoprecipitation of the hormone-ECD complex [12]. 0.022 
pmol of [“‘I]oPRL were added/tube. Preparation of iodinated 
hormones has been described previously [15]. 
2.6. Determinution of the molecular sire of rbPRLR-ECD. lartogenie 
hormone complexes by gelfiltratlon 
The molecular size of the oPRL:ECD complexes was determined by 
gel filtration, as described previously [7]. The concentration of oPRL 
in the incubation mixture was 0.5 nmol/ml and that of ECD varied 
from 0 to 2.5 nmol/ml. The reaction was carried out in 25 mM Tris- 
HCl buffer, pH 8.0, containing 10 mM MgCiz and 150 mM NaCl 
(TMN buffer). After a 60-min incubation at room temperature. 200+1 
aliquots were applied to a Superdex-75HR lo/30 column (Pharmacia. 
Uppsala, Sweden), connected to an HPLC (Waters, USA), which had 
been preequilibrated with the same buffer, prior to sample apphcation. 
The column was developed at 1 .O ml/min. at room temperature. Pro- 
tein content was monitored by absorbance at 280 nm. The interaction 
between rbPRLR-ECD or hGHR-ECD and iodinated oPRL or hGH 
was determined in 25 mM Tns-HCI buffer, pH 8.0, containing IO mM 
MgClz and 0.1% bovine serum albumm. Concentration of each of the 
radlolabelled hormones was 0.1 pmol/ml and of the ECDs, 0.0-2 0 
pmol/ml. After a 16-h preincubation , 200 $1 aliquots were applied to 
a Superdex-75HR lo/30 column, preequilibrated with the mcubatlon 
buffer and connected to an FPLC (Pharmacia, Uppsala, Sweden). The 
column was developed at 1 .O ml/min at room temperature, and 0.5 ml 
fractions were collected and monitored for radioactivity at LKB 
gamma-counter. 
3. RESULTS 
3.1. Pur$cation and characterization of rbPRLR-ECD 
Conditioned medium (1,200 ml) obtained from SF9 
cells infected with pGmAc3 E rbPRLR [12] was ad- 
justed to pH 8.0, with 25 mM Tris-HCl, 10 mM MgCl?, 
left for 60 min on ice and then centrifuged at 100,000 x g 
for 30 min. Clear supernatant was applied to an oPRL- 
Affigel column (3.5 x 2.0 cm) at 100 ml/h. The column 
and the 80 ml of overlaying supernatant were kept at 
room temperature, while the rest of the supernatant and 
the eluate were kept on ice. The column was subse- 
quently washed with 60 ml of TMN buffer, 60 ml of 
TMN buffer containing 1 M NaCl. 30 ml of TMN. then 
30 ml of TMN containing 1 M MgCI,. Finally 8 ml of 
TMN containing 4.5 M MgCl, were applied to the col- 
umn and the elution was stopped. After 15 min, the 
elution was started again with TMN buffer containing 
4.5 M MgCl,, at the rate of 30 ml/h. Fractions (2.5 ml) 
were collected in siliconized polypropylene tubes con- 
taining 2.5 ml of TMN buffer and immersed in ice. Over 
70% of the total binding activity was recovered in the 
first 12 tubes of 4.5 M MgCl, eluate (Table I). Very little 
or no binding activity was found in the earlier eluates 
or in the breakthrough fraction (not shown). The 4.5 M 
MgCl, eluate was concentrated to 1.1 ml in an Amicon 
concentrator using a YM3 membrane pretreated with 
0.01% polyvinylpolypyrrolidone (MW 360.000). The 
concentrated fraction was further separated on Super- 
dex-75HR lo/30 column equilibrated with TMN buffer, 
in four successive injections of 0.25 ml each. The col- 
umn was developed at 1 ml/min at room temperature, 
and 0.5 ml fractions were collected in siliconized pol- 
ypropylene tubes. Seventy-five percent of the protein 
and all binding activity was found in fractions eluted in 
tubes 23-25 (Fig. 1). The overall yield was 25% (Table 
I). The purified fraction was over 90% homogeneous as 
indicated by SDS-PAGE in the presence or absence of 
reducing agent (Fig. 2), and by rechromatography on 
the Superdex column (Fig. 3E). Its molecular mass esti- 
mated by SDS-PAGE, was 32 kDa, in agreement with 
that determined previously by immunoblotting [ 121. 
Western blot analysis revealed the purified ECD to be 
recognized by goat anti-PRLR polyclonal antibody 46 
(not shown). A parallel determination of molecular 
mass, from the of Superdex column profile (Figs. 3 and 
4E) yielded a value of 27 kDa. The molar extinction 
coefficient at 280 nm (63,198) was calculated using the 
molar extinction coefficients of tyrosine (1,197) and 
tryptophan (5,559), as suggested previously [ 161. 
The purified rbPRLR-ECD exhibited high affinity 
for oPRL. Scatchard analysis yielded a linear plot (not 
shown). The K, value calculated from three separate 
preparations was 25.4 rt 7.4 mM_’ (mean ? S.E.M.). 
consistent with the previously published value for non- 
purified ECD in conditioned medium [ 121. The purified 
fraction retained over 85% of its binding activity when 
stored at 4°C or -20°C for 4 weeks in siliconized pol- 
Table I 
Yield of baculovuus produced rbPRLR-ECD 






Conditioned medium 1,200 13 15,600 100.0 
4.5 MgCl, eluate 60 183 10,980 70.4 
Concentrated 4.5 MgCI, eluate 1.1 7.113 7.824 50.2 
Superdex eluate (tubes 23-25) 1.5 516 3.870 24.8 
*Calculated from the specific binding of [“‘l]oPRL. The specific radioactivity of the hgand was 70 @/mg. which corresponds to 3.54 x IO” dpm 
or 2.3 x lo6 cpm/pmol. Since 0.022 pmol of [“51]oPRL were added/tube. 1% of specific binding represents 0.22 fmol of specifically-bound 
radloactive ligand. 
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Fig. 1. Chromatography of 0.25 ml concentrated 4.5 M MgCI, affin- 
ity-column eluate, on a Superdex-75HR lo/30 column equilibrated 
with TMN buffer. The column was developed at 1 ml/min at room 
temperature and 0.5 ml fractions were collected in siliconized polypro- 
pylene tubes. Diluted aliquots corresponding to 0.004 ,~l were taken 
for determination of the specific binding (O-O). 
ypropylene tubes. Chromatography of the stored frac- 
tions on the Superdex column indicated that the slight 
loss of binding activity most probably results from ab- 
sorption of the purified fraction to the tube, and not 
from dimerization or oligomerization of the monomeric 
rbPRLR-ECD (not shown). 
3.2. Interaction with lactogenic hormones 
The stoichiometry of the interaction between purified 
rbPRLR-ECD and oPRL was studied using non-iodi- 
nated oPRL (Fig. 3). The hormone:ECD complex was 
clearly separated from its components. Its molecular 
mass was calculated using bovine serum albumin (67 
kDa), ovalbumin (43 kDa) and oPRL (23 kDa) as 
markers. At a 1: 1 ratio of rbPRLR-ECD:oPRL, over 
90% of the applied protein appeared as a complex with 
a molecular mass of ca. 50 kDa, consistent with the 
predicted value. Raising the rbPRLR-ECD:oPRL ratio 
to 5:l did not change the MW of the complex, but the 
size of the 27 kDa peak, consisting of excess rbPRLR- 
ECD, was gradually increased. 
Because of the limited amount of purified protein 
higher rbPRLR-ECD:oPRL or rbPRLR-ECD:hGH 
ratios could be obtained only by using [‘251]oPRL or 
[12’I]hGH as ligands and detecting the complex or the 
excess of the labelled hormone by measuring radioactiv- 
ity. The elution profile of the complex did not change 
at increased rbPRLR-ECD:labelled hormone ratios 
(Fig. 4A and B), and the radioactive peak eluted out in 
the 43-52 kDa range. Excess of the rbPRLR-ECD 
could not be seen, but at the 1:l ratios over 85% of the 
radioactivity already appeared in the complex. We also 
tested the interaction of [“‘I]hGH with hGHR-ECD 
(amino acids l-246), to validate our results (Fig. 4C). 
Increasing the hGHR-ECD:[‘251]hGH ratio clearly 
shifted the peak of the complex to higher MWs, indicat- 
ing a shift from the formation of 1: 1 to 2: 1 hGHR- 
ECD:[“‘I]hGH complexes. It should be noted that even 
at 1:0.5 and 1:l ratios, simultaneous formation of 2:l 
and 1: 1 complexes was observed. 
4. DISCUSSION 
Over 90% pure rbPRLR-ECD was obtained using a 
two-step protocol consisting of affinity chromatogra- 
phy on oPRL-Affigel and gel filtration. Inclusion of 10 
mM MgCl, in the conditioned medium applied to the 
affinity column and the use of siliconized polypropylene 
tubes significantly contributed to binding efficiency and 
prevented non-specific absorption of the eluted 
rbPRLR-ECD to the collection tubes. Overall yield was 
25% (Table I). The apparent value of the rbPRLR-ECD 
concentration in the conditioned medium (Table I) was 
-lo-fold lower than that reported previously [12], for 
two reasons: (i) the cells were grown in a serum-free 
medium that indeed yields less rbPRLR-ECD; (ii) the 
present value was determined from the specific binding, 







Fig. 2. Electrophoretic patterns of purified rbPRLR-ECD. SDS- 
PAGE (10%) was carried out in absence (lane 2) or presence (lane 3) 
of ,&mercaptoethanol. Lanes 1 and 4 show protein molecular weight 
markers. The gel was stained with Coomassie brilliant blue. 
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Fig. 3. Gel filtration of rbPRLR-ECD:oPRL complexes on a Super- 
dex-75HR lo/30 column. Complex formation was carried out durmg 
30 min of incubation at room temperature, using the following 
rbPRLR-ECD:oPRL ratios: (A) 5:l; (B) 4:l; (C) 3:l; (D) 2:l: (E) 1:O; 
(F) 0:l. Aliquots (200 ~1) of the incubatton mixture were applied to 
the column and complex formation was monitored by absorbance at 
280 nm. For more details see text. 
tor, as compared to a. Scatchard plot, because the bind- 
ing of the ligand is carried out at non-saturating concen- 
trations of the latter. The apparent molecular mass of 
the purified monomeric fraction as determined by SDS- 
PAGE was 32 kDa, while the value obtained from gel 
filtration was only 27 kDa. Both values were higher 
than the 22.8 kDa deduced from the cDNA sequence, 
indicating extensive glycosylation. The affinity constant 
of the purified rbPRLR-ECD for oPRL was 5-10 times 
higher than the membrane-inserted, truncated or full- 
size receptor [12]. It was, however, similar to the non- 
purified ECD in insect cells conditioned medium, indi- 
cating that increased affinity is an intrinsic property of 
this protein. 
Interaction of the purified rbPRLR-ECD with oPRL, 
[‘?]oPRL or [‘251]hGH clearly indicated that. even at 
a 20:1 rbPRLR-ECD:hormone molar ratio, only a I:1 
complex is formed. These results differ from the 2:1 
(hGHR-ECD:hGH) stoichiometry of interaction re- 
ported recently for the ECD of hGHR (hGH binding 
protein) l-238 [5,6] or l-246 [7], both expressed and 
purified from E. coli. However, it should be emphasized 
that the rbPRLR-ECD expressed in insect cells is trun- 
cated at its C-terminus by 12 amino acids and is heavily 
glycosylated [12]. Whether these differences could ac- 
count for its inability to form 2: 1 complexes is not pres- 
ently known. It should be noted, however, that trun- 
cated of eight C-terminal amino acids in the non-glyco- 
sylated hGHR-ECD did not affect binding [I 71, and 
enabled hormone-induced receptor dimerization [5,6], 
although the sequence of dimerization was slightly dif- 
ferent as compared to its non-truncated analogue ([7] 
and Fig. 4C). In addition, neither we (Sakal and Gertler, 
unpublished data) nor others (Postel-Vinay and Kelly, 
personal communication) have been successful in doc- 
umenting the formation of 2:1 complexes between gly- 
cosylated hGH binding protein from human serum and 
hGH. 
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Fig. 4. Gel filtration of [“‘I]oPRL.rbPRLR-ECD (A). 
[“51]hGH:rbPRLR-ECD (B) or [“‘I]hGH:hGHR-ECD (C) complexes 
on a Superdex-75HR lo/30 column. Complex formatton was carrted 
out during 16 h of mcubatton at room temperature. at various 
ECD:hormone ratios, Aliquots (200~1) ofthe incubation mtxture were 
applied to the column and 0.5 ml fracttons were collected and mom- 
tored for radioactivity. For more detatls see text. 
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of the 12 C-terminal amino acids of the rbPRLR-ECD 
in the putative formation of the 2:l rbPRLR- 
ECD:hormone complex should be reexamined. Since 
low amounts of the purified rbPRLR-ECD do not allow 
efficient deglycosylation experiments, this aim could be 
achieved through inspection of E. co&expressed, non- 
glycosylated, full-size and truncated rbPRLR-ECDs. 
Both constructs are currently being prepared in our lab. 
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